4
Changes in Ownership
Propanc Biopharma, Inc. Filed Acc 0001493152-19-008110
Options or other derivatives
- Chief Scientific Officer acquired 29,250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kenyon Julian Norman Chief Scientific Officer | 2019-05-14 | Grant or award · Stock Options (Right to Buy) | +9,750,000 | 9,750,000 | D | ||
| Kenyon Julian Norman Chief Scientific Officer | 2019-05-14 | Grant or award · Restricted Stock Units | +9,750,000 | 9,750,000 | D | ||
| Kenyon Julian Norman Chief Scientific Officer | 2019-05-14 | Grant or award · Restricted Stock Units | +9,750,000 | 9,750,000 | D | ||
Loading xslF345X03/ownership.xml…